Table 1 Demographics
From: Assessing the clinical utility of genetic risk scores for targeted cancer screening
Sex | |
 Male | 94 (33.45%) |
 Female | 187 (66.55%) |
Age | |
 40–49 | 56 (19.93%) |
 50–59 | 94 (33.45%) |
 60–70 | 131 (46.62%) |
Race | |
 Caucasian | 267 (95.02%) |
 African American | 9 (3.2%) |
 East Asian | 5 (1.78%) |
Family history | |
 Breast cancer | Missing: 13 |
  Male | 30 (34.09%) |
  Female | 69 (38.33%) |
 Prostate cancer | Missing: 12 |
  Male | 24 (26.67%) |
  Female | 47 (26.26%) |
 Colorectal cancer | Missing: 8 |
  Male | 23 (25.56%) |
  Female | 49 (26.78%) |